INFU Price / Book | INFUSYSTEM HOLDINGS, INC

InfuSystem Holdings, Inc Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

InfuSystem Holdings, Inc price/book ratio for the quarter ending 2026-06-30 was 3.25, a 39.61% increase year-over-year.
InfuSystem Holdings, Inc price/book ratio for the quarter ending 2026-03-31 was 3.16, a 54.27% increase year-over-year.
InfuSystem Holdings, Inc price/book ratio for the quarter ending 2025-12-31 was 3.15, a 0.87% increase year-over-year.
InfuSystem Holdings, Inc price/book ratio for the quarter ending 2025-09-30 was 3.79, a 47.71% increase year-over-year.
InfuSystem Holdings, Inc price/book ratio for fiscal 2026 was 3.25.
InfuSystem Holdings, Inc price/book ratio for fiscal 2025 was 3.15, a 0.87% increase from fiscal 2024.
InfuSystem Holdings, Inc price/book ratio for fiscal 2024 was 3.12, a 26.85% decline from fiscal 2023.
InfuSystem Holdings, Inc price/book ratio for fiscal 2023 was 4.27, a 13.67% increase from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	3.25	$192.37M	$59.15M
2026-03-31	3.16	$185.44M	$58.75M
2025-12-31	3.15	$180.67M	$57.33M
2025-09-30	3.79	$209.98M	$55.47M
2025-06-30	2.33	$127.05M	$54.53M
2025-03-31	2.05	$112.84M	$55.15M
2024-12-31	3.12	$179.75M	$57.53M
2024-09-30	2.56	$142.27M	$55.51M
2024-06-30	2.72	$145.58M	$53.49M
2024-03-31	3.49	$182.46M	$52.28M
2023-12-31	4.27	$223.41M	$52.3M
2023-09-30	3.97	$204.21M	$51.47M
2023-06-30	4.06	$202.72M	$49.96M
2023-03-31	3.36	$162.22M	$48.26M
2022-12-31	3.76	$180.39M	$48M
2022-09-30	3.02	$144.48M	$47.81M
2022-06-30	4.29	$199.29M	$46.5M
2022-03-31	4.37	$201.29M	$46.05M
2021-12-31	7.3	$352.51M	$48.27M
2021-09-30	5.78	$268.51M	$46.46M
2021-06-30	9.57	$427.56M	$44.7M
2021-03-31	9.67	$415.27M	$42.95M
2020-12-31	9.35	$381.19M	$40.75M
2020-09-30	8.83	$259.44M	$29.39M
2020-06-30	8.87	$232.34M	$26.2M
2020-03-31	7.72	$170.01M	$22.02M
2019-12-31	7.59	$169.59M	$22.33M
2019-09-30	4.83	$104.94M	$21.72M
2019-06-30	4.19	$84.79M	$20.25M
2019-03-31	5	$98.71M	$19.74M
2018-12-31	3.29	$67.34M	$20.44M
2018-09-30	3.09	$63.59M	$20.61M
2018-06-30	2.69	$79.71M	$29.66M
2018-03-31	2.11	$66.04M	$31.23M
2017-12-31	1.69	$52.4M	$30.95M
2017-09-30	0.96	$46.7M	$48.75M
2017-06-30	0.82	$39.82M	$48.7M
2017-03-31	1.05	$52.18M	$49.63M
2016-12-31	1.14	$57.81M	$50.69M
2016-09-30	1.23	$62.93M	$50.98M
2016-06-30	1.15	$58.82M	$50.96M
2016-03-31	1.57	$79.44M	$50.67M
2015-12-31	1.35	$68.08M	$50.32M
2015-09-30	1.28	$62.01M	$48.52M
2015-06-30	1.51	$71.57M	$47.26M
2015-03-31	1.31	$60.46M	$46.22M
2014-12-31	1.51	$70.27M	$46.45M
2014-09-30	1.54	$69.72M	$45.28M
2014-06-30	1.33	$58.84M	$44.36M
2014-03-31	1.41	$61.16M	$43.45M
2013-12-31	1.1	$47M	$42.72M
2013-09-30	0.68	$28.27M	$41.62M
2013-06-30	0.8	$32.62M	$40.81M
2013-03-31	0.94	$37.94M	$40.52M
2012-12-31	0.82	$32.7M	$40.01M
2012-09-30	0.97	$38.34M	$39.34M
2012-06-30	1.02	$40.13M	$39.2M
2012-03-31	1.04	$41M	$39.54M
2011-12-31	0.85	$34.02M	$40.17M
2011-09-30	0.49	$20M	$40.72M
2011-06-30	0.8	$45.47M	$57.15M
2010-12-31	0.58	$49.2M	$85.14M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	3.25	$192.37M	$59.15M
2025-12-31	3.15	$180.67M	$57.33M
2024-12-31	3.12	$179.75M	$57.53M
2023-12-31	4.27	$223.41M	$52.3M
2022-12-31	3.76	$180.39M	$48M
2021-12-31	7.3	$352.51M	$48.27M
2020-12-31	9.35	$381.19M	$40.75M
2019-12-31	7.59	$169.59M	$22.33M
2018-12-31	3.29	$67.34M	$20.44M
2017-12-31	1.69	$52.4M	$30.95M
2016-12-31	1.14	$57.81M	$50.69M
2015-12-31	1.35	$68.08M	$50.32M
2014-12-31	1.51	$70.27M	$46.45M
2013-12-31	1.1	$47M	$42.72M
2012-12-31	0.82	$32.7M	$40.01M
2011-12-31	0.85	$34.02M	$40.17M
2010-12-31	0.58	$49.2M	$85.14M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)	United States	$0.238B	20.93
Anika Therapeutics, Inc. (ANIK)	United States	$0.272B	-51.71
ORASURE TECHNOLOGIES INC (OSUR)	United States	$0.272B	-6.26
PRO DEX INC (PDEX)	United States	$0.234B	13.64
Cytosorbents Corp (CTSO)	United States	$0.274B	-1.29
TriSalus Life Sciences, Inc. (TLSI)	United States	$0.283B	-9.92
Neuronetics, Inc. (STIM)	United States	$0.216B	-3.25
Mobia Medical, Inc. (MOBI)	United States	$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)	United States	$0.297B	-4.32
Profound Medical Corp. (PROF)		$0.206B	-7.37